About
our President
Stuart
B Levy, MD, Professor of Medicine and of Molecular Biology and Microbiology,
is the Director of the Center for Adaptation Genetics and Drug Resistance
at Tufts University School of Medicine and Staff Physician at the
New England Medical Center. He also serves as President of the Alliance
for the Prudent Use of Antibiotics, an international organization
with members in over 90 countries of the world.
A magna cum laude, Phi Beta Kappa graduate of Williams College,
Dr. Levy received his medical degree from the University of Pennsylvania.
He did his residency at Mt. Sinai Hospital in New York and postdoctoral
research at the National Institutes of Health, Bethesda.
Dr. Levy is well known for his contributions to the antibiotic resistance
field. He has published over 200 papers on antibiotic use and resistance,
and has edited three books and two special journal editions devoted
to the subject. His 1992 book, The
Antibiotic Paradox: How Miracle Drugs Are Destroying the
Miracle,
has been cited widely in both the lay and scientific media. It presents
the conflicting consequences of antibiotic use--curing disease and
selecting resistant bacteria. In the book he stresses increased
awareness of the problems of antibiotic misuse and resistance, and
outlines an approach towards improving antibiotic usage and efficacy
worldwide.
Dr. Levy led the discovery of the first characterized energy-dependent
antibiotic efflux mechanism and efflux protein, that for tetracycline
resistance. He has written extensively about efflux as a mechanism
for drug resistance. His interests have expanded to the phenomenon
of multidrug resistance in bacterial and mammalian cells, including
the discovery of a regulatory locus mar for intrinsic multiple
antibiotic resistance/susceptibility among the Enterobacteriaceae
and new efflux systems for chemotherapeutic agents among mammalian
cells.
Dr. Levy is a Fellow of the American College of Physicians, Infectious
Disease Society of America, and the American Academy of Microbiology.
He has organized and chaired four international meetings on drug
resistance and was Chairperson of the US Fogarty Center three-year
international study of "Antibiotic use and resistance worldwide".
He has been, and continues to be, a consultant to international
and national organizations and agencies, including the World Health
Organization in Geneva and Southeast Asia, the US FDA and US EPA.
He is an Editor of Plasmid and serves on a number of Editorial
Boards, including Antimicrobial Agents & Chemotherapy.
He has been a Lecturer for the American Society for Microbiology
Foundation and the Australia Society for Microbiology. He has served
twice as a member of the Comite Scientifique díEvaluation of the
Pasteur Institut, Paris. He was a member of the Advisory Panel for
the US Office of Technology Assessment report on antibiotic resistant
bacteria. He was awarded the 1995 Hoechst-Roussel Award for esteemed
research in antimicrobial chemotherapy by the American Society for
Microbiology. He is the President of the American Society for Microbiology.
Dr. Levy has been featured and quoted for his work on antibiotic
use and resistance in major national and international newspapers
and magazines including Time, Newsweek, US News
and World Report, New Yorker, New York Times,
Washington Post, USA Today, Chicago Tribune,
and San Francisco Chronicle. He has appeared on Good Morning
America, Nova, the Today Show, Fox Front Page,
ABC Prime Time, CBS 48 Hours, CNN, Canadian national
television, Japanese public television, and all major US television
network news shows. He was featured in the March 28, 1994, Newsweek
cover story on antibiotic resistance. More recently, he appeared
on CBS This Morning and the Jim Lehrer News Hour. |
